Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cortexyme Inc (CRTX)

Cortexyme Inc (CRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,074,022
  • Shares Outstanding, K 29,498
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,980 K
  • 60-Month Beta 0.76
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.34
Trade CRTX with:

Options Overview

Details
  • Implied Volatility 99.02%
  • Historical Volatility 183.82%
  • IV Percentile 31%
  • IV Rank 13.38%
  • IV High 242.04% on 11/04/20
  • IV Low 76.94% on 12/07/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 460
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 394
  • Open Int (30-Day) 1,847

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.70
  • Number of Estimates 4
  • High Estimate -0.56
  • Low Estimate -0.79
  • Prior Year -0.46
  • Growth Rate Est. (year over year) -52.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.51 +19.25%
on 02/17/21
52.80 -33.35%
on 02/04/21
-9.97 (-22.08%)
since 02/03/21
3-Month
26.66 +31.99%
on 12/29/20
52.80 -33.35%
on 02/04/21
-12.76 (-26.61%)
since 12/03/20
52-Week
26.66 +31.99%
on 12/29/20
58.99 -40.35%
on 11/20/20
-10.06 (-22.23%)
since 03/03/20

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX

, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cortexyme, Inc. ("Cortexyme" or the "Company") (NASDAQ: CRTX). Such investors are advised to contact at  or 888-476-6529,...

CRTX : 35.19 (-3.35%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX

New York, New York--(Newsfile Corp. - February 22, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Cortexyme, Inc. ("Cortexyme" or the "Company") (NASDAQ: CRTX). Such investors...

CRTX : 35.19 (-3.35%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX

NEW YORK, NY / ACCESSWIRE / February 20, 2021 / Pomerantz LLP is investigating claims on behalf of investors of Cortexyme, Inc. ("Cortexyme" or the "Company") (NASDAQ:CRTX). Such investors are advised...

CRTX : 35.19 (-3.35%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX

, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ofCortexyme, Inc. ("Cortexyme" or the "Company") (NASDAQ: CRTX). Such investors are advised to contact at or 888-476-6529,...

CRTX : 35.19 (-3.35%)
Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Cortexyme, Inc. (CRTX) Investigation

NEW YORK, NY / ACCESSWIRE / February 18, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cortexyme, Inc. ("Cortexyme" or "the Company") (NASDAQ:CRTX)....

CRTX : 35.19 (-3.35%)
Biotech Stock Roundup: REGN's Drug Approval & Pipeline Updates From AMGN, BLUE

The biotech sector was in focus last week with regulatory and pipeline updates from quite a few companies like Regeneron (REGN), Amgen (AMGN) and bluebird (BLUE).

REGN : 446.73 (-1.79%)
AMGN : 223.94 (-0.78%)
CRTX : 35.19 (-3.35%)
BLUE : 29.34 (-4.74%)
ACIU : 7.33 (-5.17%)
Cortexyme Provides Regulatory Update on Development Program for Atuzaginstat in Alzheimer's Disease

--- Open-Label Extension of atuzaginstat to stop dosing and enrollment

CRTX : 35.19 (-3.35%)
Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginstat and Pipeline Expansion

Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer's disease on schedule to be announced in Q4 2021 and a pipeline of therapeutics for degenerative diseases, today announced...

CRTX : 35.19 (-3.35%)
Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones

---- Atuzaginstat to be studied in the PEAK trial, a new Phase 2 study for Parkinson's disease

CRTX : 35.19 (-3.35%)
Is the Options Market Predicting a Spike in Cortexyme (CRTX) Stock?

Investors need to pay close attention to Cortexyme (CRTX) stock based on the movements in the options market lately.

CRTX : 35.19 (-3.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cortexyme Inc. is a clinical-stage biopharmaceutical company. It is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The company's drug candidate consists of COR388 which is in clinical stage. Cortexyme Inc. is based in San Francisco, United States....

See More

Key Turning Points

3rd Resistance Point 37.68
2nd Resistance Point 37.12
1st Resistance Point 36.15
Last Price 35.19
1st Support Level 34.63
2nd Support Level 34.07
3rd Support Level 33.10

See More

52-Week High 58.99
Fibonacci 61.8% 46.64
Fibonacci 50% 42.83
Fibonacci 38.2% 39.01
Last Price 35.19
52-Week Low 26.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar